LENZ Therapeutics, Inc. ($LENZ)
Schimmelpennink Evert B. โ Director
Shares
28,089
Price
$8.95
Total Value
$251,410.59
P&L
-6.2% ($15,462.99)
Nearby Earnings
Mar 18, 2026
EPS:Est: -0.91
Revenue:Est: $3.09M
Mar 24, 2026
EPS:Est: -0.91
Revenue:Est: $3.09M
Transaction Details
| Insider | Schimmelpennink Evert B. |
|---|---|
| Title | Director |
| Transaction Date | Mar 27, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 30, 2026 |
| Shares Purchased | 28,089 |
| Price per Share | $8.95 |
| Total Value | $251,410.59 |
| Shares Owned After | 77,289 |
| Derivative | No |
| Accession Number | 0001713795-26-000004 |
| Document | View SEC Filing |